FIELD: biotechnology.
SUBSTANCE: novel HER2/neu-binding molecule has been proposed. A pharmaceutical composition containing said binding molecules and the use of said molecules for the treatment of diseases and conditions associated with HER2/Neu expression, such as cancer, are also proposed.
EFFECT: obtaining binding molecules with improved binding affinity for HER2 and improved stability.
12 cl, 81 dwg, 15 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
| TRISPECIFIC BINDING MOLECULES, WHICH SPECIFICALLY BIND ANTIGENS OF A VARIETY OF MALIGNANT TUMORS, AND METHODS OF USING THEM | 2015 |
|
RU2718692C2 |
| VARIANT CD3 BINDING DOMAINS AND THEIR USE IN COMBINATION THERAPY FOR TREATMENT OF DISEASES | 2019 |
|
RU2810222C2 |
| COVALENT DIANTIBODIES AND USE THEREOF | 2009 |
|
RU2593720C2 |
| BISPECIFIC BINDING AGENTS WITH INTERSPECIFIC SPECIFICITY | 2008 |
|
RU2535992C2 |
| COMBINED THERAPY FOR MALIGNANT TUMOR TREATMENT | 2016 |
|
RU2733315C2 |
| BINDING MOLECULES INDUCING CELLULAR ACTIVATION | 2019 |
|
RU2770620C1 |
| METHODS FOR USING CD32B x CD79B-BINDING MOLECULES IN TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS | 2017 |
|
RU2772434C2 |
| COVALENT DIABODIES AND USE THEREOF | 2009 |
|
RU2744176C2 |
| MOLECULES WHICH BIND TO 4-1BB | 2011 |
|
RU2710717C2 |
